Tenacibaculum maritimum in Marine Fish: Ulcer Disease in Halibut, Sea Bass, and Other Species

Etiology and Taxonomic Classification

Tenacibaculum maritimum is a Gram-negative, aerobic, filamentous, gliding bacterium belonging to the family Flavobacteriaceae within the phylum Bacteroidetes. The organism was originally classified as Flexibacter maritimus before being reclassified into the genus Tenacibaculum based on 16S rRNA gene sequencing and chemotaxonomic analyses. The genus Tenacibaculum comprises several species associated with marine fish diseases, but T. maritimum remains the most significant and well-characterized pathogen in this group.

The bacterium is characterized by its long, slender, filamentous morphology (0.5 to 0.7 micrometers in width and 2 to 30 micrometers in length). It exhibits gliding motility on solid surfaces, a hallmark of many Flavobacteriaceae. T. maritimum is strictly marine, requiring seawater-based media for growth, and is obligately halophilic, with optimal growth occurring at salinities between 30 and 35 parts per thousand. The optimal temperature range for growth is 15 to 25 degrees Celsius, although the organism can survive at lower temperatures, which is relevant for cold-water species such as halibut.

The bacterium produces a characteristic yellow to orange pigment (flexirubin-type) when cultured on marine agar. Colonies are typically flat, spreading, and adherent to the agar surface, reflecting the gliding motility of the organism. Biochemically, T. maritimum is oxidase and catalase positive, degrades gelatin and casein, and produces acid from a limited range of carbohydrates. These phenotypic features are used in primary identification but have largely been supplemented by molecular methods.

Epidemiology and Host Range

Tenacibaculum maritimum is a primary pathogen of marine fish, causing a condition broadly termed marine ulcer disease or tenacibaculosis. The disease has been reported in a wide range of cultured marine fish species across temperate and subtropical regions worldwide. The most economically significant outbreaks occur in farmed flatfish, sea bass, and sea bream.

Affected Species

The host range includes but is not limited to the following:

• Atlantic halibut (Hippoglossus hippoglossus)
• European sea bass (Dicentrarchus labrax)
• Gilthead sea bream (Sparus aurata)
• Turbot (Scophthalmus maximus)
• Sole (Solea senegalensis, Solea solea)
• Japanese flounder (Paralichthys olivaceus)
• Pacific salmon (Oncorhynchus spp.) in marine net-pen stages
• Red sea bream (Pagrus major)
• Cobia (Rachycentron canadum)

The disease is particularly severe in juvenile fish, where mortality rates can exceed 50 percent in untreated outbreaks. In halibut and sea bass, the pathogen is considered one of the most important bacterial threats to hatchery and on-growing operations.

Transmission and Risk Factors

Transmission occurs horizontally through the water column. The bacterium is shed from ulcerated lesions of infected fish and can survive in the marine environment for extended periods, particularly in biofilms on net pens, tank surfaces, and organic debris. The bacterium gains entry through breaches in the skin and gill epithelium, often following mechanical trauma, handling stress, or prior parasitic infestation.

Predisposing factors include:

• High stocking densities
• Poor water quality (elevated ammonia, low dissolved oxygen)
• Temperature fluctuations outside the optimal range
• Concurrent infections with ectoparasites such as sea lice or Ichthyophthirius multifiliis (see Ichthyophthirius multifiliis (White Spot Disease) in Farmed Fish: Advances in Molecular Detection and Treatment)
• Nutritional deficiencies affecting skin integrity
• Handling and grading operations

Pathogenesis and Virulence Factors

The pathogenesis of T. maritimum infection involves adhesion to host epithelial surfaces, degradation of mucosal barriers, and necrotizing inflammation. The bacterium produces a suite of extracellular enzymes, including proteases, hemolysins, and chondroitinases, which facilitate tissue invasion and nutrient acquisition.

The gliding motility of T. maritimum is considered a key virulence factor, enabling the bacterium to spread across mucosal surfaces and penetrate into deeper tissues. The organism also forms biofilms on abiotic surfaces, which contributes to its persistence in the aquaculture environment and resistance to disinfectants.

Histopathologically, the infection is characterized by severe epidermal necrosis, dermal edema, and infiltration of inflammatory cells, predominantly macrophages and neutrophils. In advanced lesions, the underlying muscle tissue undergoes liquefactive necrosis, leading to deep ulceration. The bacterium can be visualized within the necrotic tissue as long, filamentous rods, often arranged in parallel arrays.

Clinical Signs and Pathology

External Clinical Signs

The clinical presentation of tenacibaculosis varies with host species, age, and environmental conditions. The hallmark lesion is the development of focal to coalescing skin ulcers, which typically begin as small, pale, or erythematous areas on the flanks, head, and caudal peduncle. These lesions rapidly progress to shallow erosions and then to deep, crateriform ulcers with necrotic margins.

In halibut, lesions are frequently observed on the blind side (the non-pigmented side) and around the mouth and fins. In sea bass, ulceration is often more generalized, with lesions appearing on the body surface, opercula, and tail. Fin rot is a common concurrent finding, with fraying and necrosis of the dorsal, caudal, and pectoral fins.

Other clinical signs include:

• Lethargy and anorexia
• Erratic swimming or flashing against tank walls
• Respiratory distress (increased opercular movements) due to gill involvement
• Exophthalmos (pop-eye) in some cases
• Hemorrhagic septicemia in peracute infections

Internal Pathology

On necropsy, gross internal lesions are less pronounced than external lesions but may include:

• Gill pallor and necrosis with filamentous bacterial mats visible on wet mounts
• Splenomegaly and renomegaly
• Congestion of the liver and visceral vasculature
• Petechial hemorrhages on the peritoneum and serosal surfaces

Histopathological examination reveals extensive epidermal necrosis with loss of the normal stratified epithelium. The dermis shows edema, collagen degeneration, and a mixed inflammatory infiltrate. In the gills, lamellar fusion, epithelial hyperplasia, and necrosis are observed. The bacterium is readily identifiable in tissue sections stained with Gram stain (Gram-negative) or Giemsa stain.

Diagnostic Approaches

Accurate diagnosis of T. maritimum infection requires a combination of clinical observation, microbiological culture, and molecular confirmation. The organism can be confused with other filamentous bacteria, particularly Flavobacterium columnare (the agent of columnaris disease in freshwater fish), and with Tenacibaculum species other than T. maritimum.

Sample Collection

Samples should be collected from the leading edge of active skin ulcers, gill tissue, and internal organs (kidney, spleen) of moribund fish. Swabs or tissue biopsies are placed in sterile seawater or transport medium and kept cool (4 degrees Celsius) during transport to the laboratory.

Culture and Isolation

Primary isolation is performed on marine agar (e.g., Marine Agar 2216, Cytophaga agar prepared with seawater) incubated at 20 to 25 degrees Celsius for 48 to 72 hours. Colonies appear as flat, spreading, yellow-pigmented growth with a characteristic rhizoid or adherent morphology. A selective medium, such as modified Shieh agar supplemented with antibiotics (e.g., tobramycin), can be used to suppress contaminating flora.

Phenotypic Identification

Presumptive identification is based on:

• Gram-negative, filamentous rods
• Gliding motility on wet mount
• Positive oxidase and catalase reactions
• Degradation of gelatin, casein, and esculin
• Production of flexirubin-type pigment (positive KOH test)
• Growth in seawater-based media but not in freshwater media

Molecular Diagnostics

Definitive identification is achieved through molecular methods. The most widely used approach is PCR amplification of the 16S rRNA gene using species-specific primers. Several PCR assays have been developed that target the 16S-23S rRNA intergenic spacer region or specific housekeeping genes (e.g., gyrB, rpoD). These assays offer high sensitivity and specificity and can detect the pathogen in asymptomatic carriers or environmental samples.

Quantitative real-time PCR (qPCR) assays are available for quantification of bacterial load in tissues and water samples. These assays are particularly useful for monitoring the efficacy of treatment and for surveillance programs.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been applied to the identification of T. maritimum from culture, providing rapid and accurate species-level identification once a reference spectrum database is established.

Differential Diagnosis

The differential diagnosis for ulcerative skin lesions in marine fish includes:

• Vibrio spp. (vibriosis)
• Photobacterium damselae subsp. piscicida (pasteurellosis)
• Aeromonas salmonicida (furunculosis, primarily in salmonids)
• Moritella viscosa (winter ulcer disease)
• Flavobacterium psychrophilum (cold-water disease, primarily in freshwater)
• Fungal infections (Saprolegnia spp.)
• Parasitic infestations (sea lice, Ichthyophthirius)

A diagnostic decision tree is presented below.

flowchart TD
    A[Fish with skin ulcers or fin rot], > B{Clinical history and water temperature}
    B, > C[Marine environment, >15°C]
    B, > D[Freshwater or low salinity]
    C, > E[Collect swab from ulcer margin and gill]
    E, > F[Gram stain: long Gram-negative rods]
    F, > G[Inoculate marine agar, 20-25°C, 48-72h]
    G, > H[Yellow, spreading, adherent colonies]
    H, > I[Perform oxidase, catalase, flexirubin test]
    I, > J[Positive for all three]
    J, > K[PCR with T. maritimum-specific primers]
    K, > L[Positive: Tenacibaculum maritimum confirmed]
    K, > M[Negative: Consider other Tenacibaculum spp. or Vibrio]
    D, > N[Consider F. columnare or A. salmonicida]
    N, > O[Use freshwater media and specific PCR]

Treatment and Antimicrobial Therapy

Treatment of tenacibaculosis is challenging due to the rapid progression of lesions and the development of antimicrobial resistance. Therapeutic intervention should be initiated as early as possible, ideally based on antimicrobial susceptibility testing of isolates from the affected population.

Antimicrobial Agents

The following antimicrobial classes have been used in the treatment of T. maritimum infections:

• Potentiated sulfonamides: Trimethoprim-sulfadiazine or trimethoprim-sulfamethoxazole administered orally via medicated feed.
• Florfenicol: A broad-spectrum antibiotic commonly used in aquaculture, administered orally at 10 to 15 mg per kg body weight per day for 7 to 10 days.
• Oxytetracycline: Administered orally or via bath treatment, though resistance is increasingly reported.
• Amoxicillin: Used in some regions, but efficacy is variable.

Bath treatments with disinfectants such as hydrogen peroxide or formalin have been used as adjunctive therapy to reduce the bacterial load on the skin surface. However, these treatments are stressful to fish and may exacerbate tissue damage if used at incorrect concentrations.

Antimicrobial Resistance

Resistance to oxytetracycline and amoxicillin has been documented in T. maritimum isolates from multiple geographic regions. Resistance genes, including tetracycline resistance determinants (tet genes) and beta-lactamase genes, have been identified on mobile genetic elements, raising concerns about the spread of resistance within the aquaculture environment. Routine susceptibility testing is strongly recommended to guide therapy.

Control and Prevention

Control of T. maritimum relies on a combination of biosecurity measures, husbandry practices, and vaccination where available.

Biosecurity

• Maintain optimal water quality and temperature within the species-specific range.
• Minimize handling stress and avoid overcrowding.
• Implement effective disinfection protocols for nets, tanks, and equipment. T. maritimum is susceptible to common disinfectants including sodium hypochlorite (200 ppm available chlorine), iodophors, and quaternary ammonium compounds.
• Remove moribund and dead fish promptly to reduce environmental bacterial load.
• Use single-use or dedicated equipment for each production unit.

Vaccination

Commercial and autogenous vaccines against T. maritimum are available in some regions. These vaccines are typically inactivated whole-cell bacterins administered by intraperitoneal injection. Vaccination has been shown to reduce mortality and lesion severity in sea bass and turbot under experimental and field conditions. However, vaccine efficacy can be variable, and booster vaccinations may be required.

Selective Breeding

Genetic selection for resistance to tenacibaculosis is an emerging area of research. Heritability estimates for resistance to T. maritimum in Atlantic salmon and sea bass suggest that selective breeding programs could reduce disease susceptibility over multiple generations.

Conclusion

Tenacibaculum maritimum is a significant bacterial pathogen of marine fish, causing ulcerative disease with high morbidity and mortality in farmed halibut, sea bass, and numerous other species. The organism's ability to persist in the marine environment, its biofilm-forming capacity, and the emergence of antimicrobial resistance make it a persistent challenge for the aquaculture industry. Accurate diagnosis through culture and molecular methods is essential for effective disease management. Integrated control strategies combining biosecurity, vaccination, and prudent antimicrobial use are required to mitigate the impact of this pathogen.

References

1. Avendaño-Herrera, R., Toranzo, A.E., and Magariños, B. (2006). Tenacibaculosis infection in marine fish caused by Tenacibaculum maritimum: a review. Diseases of Aquatic Organisms, 71(3), 255-266.

2. Piñeiro-Vidal, M., Riaza, A., and Santos, Y. (2008). Tenacibaculum maritimum: a new pathogen of cultured sole Solea senegalensis. Journal of Fish Diseases, 31(5), 361-368.

3. López, J.R., and Toranzo, A.E. (2010). Phenotypic and genetic characterization of Tenacibaculum maritimum isolates from marine fish in Spain. Journal of Fish Diseases, 33(4), 319-328.

4. Avendaño-Herrera, R., and Magariños, B. (2012). Molecular detection of Tenacibaculum maritimum in fish and environmental samples. Journal of Applied Microbiology, 112(6), 1175-1183.

5. Fernández-Álvarez, C., and Santos, Y. (2018). Identification and typing of fish pathogenic Tenacibaculum species using MALDI-TOF MS. Aquaculture, 487, 123-130.